Therapy

In an early new year boost for Calvert Reconnections, case managers and NHS clinicians throughout the UK have praised the centre’s “life-changing” approach to ABI rehabilitation. Following recent experience days and visits to the Keswick-based residential centre, a range of brain injury professionals have shared their thoughts. “Calvert Reconnections is an amazing place,” said Jamie [...]

The US military is to conduct research and clinical trials to determine whether cannabis and psychedelics can help treat service members with TBI and PTSD.

Video reminds of need to be mindful of inclusive communication needs this festive season

A novel drug designed to treat apathy in Parkinson's disease patients is ready to begin clinical trials.

The team at Nottingham Brain Injury Rehabilitation Centre discuss the importance of multi-disciplinary working

Daniel Thomas, managing director of Chroma, discusses further

Chroma discuss how it can be a valuable tool in self-expression after brain injury

NR Times reports on how the pioneering work of Aprinoia Therapeutics could influence better patient outcomes in neuro-rehab; in conversation with chief medical officer Bradford Navia. ‘Precision neuroscience’ is a term which encapsulates the ceaseless drive for more targeted and effective brain treatments and diagnoses. Not to be confused with Elon Musk’s neuro-tech startup of the same name, it sits at the intersect between two emergent health innovation trends; the rise of precision medicine – tailored interventions that consider genes, environments and lifestyles – and an acceleration of our understanding of the neurological world. On the frontline of the precision neuroscience movement is Aprinoia, a clinical-stage biotech headquartered in Boston which is opening up new possibilities for the diagnosis and treatment of neuro conditions including Alzheimer’s and Parkinson’s.

Delivering benefits to children with Cerebral Palsy who are receiving post-operative physiotherapy support